pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 29·1 min read
save

Health AI discourse shifts from hype to practical discussion, says STAT newsletter

Apr 29, 2026·read at STAT ↗Positive

Brittany Trang, a health‑tech reporter at STAT, reflects on how the conversation around artificial intelligence in healthcare is changing. In her AI Prognosis newsletter she notes that the industry may be moving past the early hype phase.

The piece argues that discussions are becoming more grounded, focusing on realistic applications rather than lofty promises. This shift, she suggests, could lead to clearer expectations among clinicians, investors, and policymakers.

Trang cites a recent video by Nilay Patel of The Verge, which critiques the notion of a "software brain" that treats the world as a manipulable database. The critique highlights a gap between AI developers and the broader healthcare community.

By acknowledging these gaps, the article encourages a more nuanced dialogue about how AI can be integrated into healthcare practice, emphasizing practical benefits over sensational claims.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Why conversations around health AI may be evolving beyond hype”

read at STAT ↗
554 words · retrieved Apr 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
InSilico Medicine

related stories

  • 4d agoCerevance Parkinson’s drug shortens 'off time' in Ph. 3, paving path to FDABioSpace
  • Sep 24Lilly’s latest China drug deal; Immunovant’s setback in lupusBioPharma Dive
  • Sep 22Deep Dive: How AI is now essential in biopharmaBioSpace
  • Sep 16Novo looks to Anthropic’s AI models to ‘supercharge’ drug developmentBioPharma Dive
  • Sep 11Owkin, Servier ink oncology R&D deal to guide discovery and trial designFierce Biotech